FSD Phar­ma scoops GW Phar­ma ex­ec to guide cannabi­noid de­vel­op­ment; Zealand Phar­ma is look­ing for a new CEO

→ Just a month af­ter GW Phar­ma­ceu­ti­cals launched its pi­o­neer­ing cannabis-de­rived drug in the US, its head of mar­ket­ing has jumped …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.